Lotus Pharmaceutical Statistics
Total Valuation
TPE:1795 has a market cap or net worth of TWD 58.91 billion. The enterprise value is 66.54 billion.
Market Cap | 58.91B |
Enterprise Value | 66.54B |
Important Dates
The last earnings date was Friday, March 14, 2025.
Earnings Date | Mar 14, 2025 |
Ex-Dividend Date | Aug 5, 2024 |
Share Statistics
TPE:1795 has 265.35 million shares outstanding. The number of shares has increased by 0.53% in one year.
Current Share Class | n/a |
Shares Outstanding | 265.35M |
Shares Change (YoY) | +0.53% |
Shares Change (QoQ) | +0.64% |
Owned by Insiders (%) | 0.64% |
Owned by Institutions (%) | 6.60% |
Float | 163.68M |
Valuation Ratios
The trailing PE ratio is 11.54 and the forward PE ratio is 10.85.
PE Ratio | 11.54 |
Forward PE | 10.85 |
PS Ratio | 3.13 |
PB Ratio | 2.78 |
P/TBV Ratio | 5.98 |
P/FCF Ratio | 10.15 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.93, with an EV/FCF ratio of 11.47.
EV / Earnings | 13.14 |
EV / Sales | 3.58 |
EV / EBITDA | 8.93 |
EV / EBIT | 10.77 |
EV / FCF | 11.47 |
Financial Position
The company has a current ratio of 2.14, with a Debt / Equity ratio of 0.65.
Current Ratio | 2.14 |
Quick Ratio | 1.63 |
Debt / Equity | 0.65 |
Debt / EBITDA | 1.83 |
Debt / FCF | 2.36 |
Interest Coverage | 11.01 |
Financial Efficiency
Return on equity (ROE) is 26.30% and return on invested capital (ROIC) is 12.11%.
Return on Equity (ROE) | 26.30% |
Return on Assets (ROA) | 10.57% |
Return on Invested Capital (ROIC) | 12.11% |
Return on Capital Employed (ROCE) | 19.52% |
Revenue Per Employee | 16.91M |
Profits Per Employee | 4.61M |
Employee Count | 1,099 |
Asset Turnover | 0.51 |
Inventory Turnover | 2.01 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -22.10% in the last 52 weeks. The beta is 0.44, so TPE:1795's price volatility has been lower than the market average.
Beta (5Y) | 0.44 |
52-Week Price Change | -22.10% |
50-Day Moving Average | 264.54 |
200-Day Moving Average | 272.99 |
Relative Strength Index (RSI) | 27.89 |
Average Volume (20 Days) | 1,398,336 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPE:1795 had revenue of TWD 18.58 billion and earned 5.07 billion in profits. Earnings per share was 19.23.
Revenue | 18.58B |
Gross Profit | 10.92B |
Operating Income | 6.18B |
Pretax Income | 6.36B |
Net Income | 5.07B |
EBITDA | 7.33B |
EBIT | 6.18B |
Earnings Per Share (EPS) | 19.23 |
Balance Sheet
The company has 6.03 billion in cash and 13.67 billion in debt, giving a net cash position of -7.64 billion or -28.78 per share.
Cash & Cash Equivalents | 6.03B |
Total Debt | 13.67B |
Net Cash | -7.64B |
Net Cash Per Share | -28.78 |
Equity (Book Value) | 21.18B |
Book Value Per Share | 79.81 |
Working Capital | 9.66B |
Cash Flow
In the last 12 months, operating cash flow was 6.15 billion and capital expenditures -353.84 million, giving a free cash flow of 5.80 billion.
Operating Cash Flow | 6.15B |
Capital Expenditures | -353.84M |
Free Cash Flow | 5.80B |
FCF Per Share | 21.86 |
Margins
Gross margin is 58.78%, with operating and profit margins of 33.25% and 27.26%.
Gross Margin | 58.78% |
Operating Margin | 33.25% |
Pretax Margin | 34.22% |
Profit Margin | 27.26% |
EBITDA Margin | 39.45% |
EBIT Margin | 33.25% |
FCF Margin | 31.21% |
Dividends & Yields
This stock pays an annual dividend of 5.73, which amounts to a dividend yield of 2.37%.
Dividend Per Share | 5.73 |
Dividend Yield | 2.37% |
Dividend Growth (YoY) | 34.32% |
Years of Dividend Growth | 4 |
Payout Ratio | 24.32% |
Buyback Yield | -0.53% |
Shareholder Yield | 1.85% |
Earnings Yield | 8.60% |
FCF Yield | 9.85% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
TPE:1795 has an Altman Z-Score of 4.08.
Altman Z-Score | 4.08 |
Piotroski F-Score | n/a |